About the Authors
- Timothée Bruel
-
Affiliations Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France, Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France
- Stéphanie Dupuy
-
Affiliations Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France, Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France
- Thomas Démoulins
-
Affiliations Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France, Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France
- Christine Rogez-Kreuz
-
Affiliation Neurovirology Laboratory, Bertin Pharma, Fontenay-aux-Roses, France
- Jacques Dutrieux
-
Affiliations Université Paris Descartes, Sorbonne Paris Cité, Paris, France, INSERM, U1016, Institut Cochin, Paris, France, CNRS, UMR8104, Paris, France, Université Paris Diderot, Paris, France
- Aurélien Corneau
-
Affiliation Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France
- Antonio Cosma
-
Affiliations Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France, Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France
- Rémi Cheynier
-
Affiliations INSERM, U1016, Institut Cochin, Paris, France, CNRS, UMR8104, Paris, France, Université Paris Diderot, Paris, France
- Nathalie Dereuddre-Bosquet
-
Affiliations Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France, Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France
- Roger Le Grand
-
Affiliations Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France, Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France
- Bruno Vaslin
-
* E-mail: bruno.vaslin@cea.fr
Affiliations Division of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France, Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: BV TB TD NDB SD. Performed the experiments: TB TD CRK JD SD ACor. Analyzed the data: TB SD JD RC ACos BV RLG NDB. Contributed reagents/materials/analysis tools: ACos RC. Wrote the paper: TB BV.